ADHD spend to increase 13-fold

Attention-deficiency hyperactivity disorder (ADHD) drug costs for the NHS are set to soar with increased diagnosis of the condition in children and adolescents in the UK, claim German researchers.

The estimated £7 million spend on ADHD by the NHS in 2002 is expected to rise to between £49 and £101 million a year by 2012. The overall drug expenditure by individual doctors for ADHD may increase nine-fold.

Professor Michael Schlander, from the University of Heidelberg calculated the range of possible costs by considering likelihood of diagnosis and treatment, the level of treatment and drug costs.

The calculation is based on the assumption that ADHD has, until recently, been undiagnosed in the UK. In turn, the number of scrips for ADHD drugs has increased.

A BBC Panorama programme led to reports that the drugs offer no long-term benefit.

These claims were based on a three-year follow-up study that showed little difference between children with ADHD managed with drugs and those given behavioural or routine care.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Houses of Parliament

GP partnerships 'like collapsing Jenga stack' after Javid threat to nationalise practices

Sajid Javid's decision to back a report calling for the end of the GMS contract within...

£20 notes spread out

VAT trap for PCNs could strip millions of pounds from general practice

Tens of millions of pounds could be stripped from general practice because work carried...

Talking General Practice logo

Podcast: Is the BMA representing GPs effectively, why GPs face a pension tax hit, and views on the workload crisis

In our regular news review the team discusses representation of GPs, a new survey...

Man sleeping

NICE guidance on insomnia backs app to replace sleeping pills

Hundreds of thousands of people with insomnia could be offered treatment via a mobile...

Health worker prepares a dose of COVID-19 vaccine

JCVI backs autumn COVID-19 booster campaign for high-risk adults and NHS staff

Frontline health and social care staff and adults at increased risk of severe illness...

GP consultation

Government accused of 'misleading' claims on general practice workforce

GP leaders have accused the government of making misleading claims about the general...